Business Services
Medical
Biotechnology

Medpace

$57.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.91 (1.60%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Medpace and other stocks, options, ETFs, and crypto commission-free!

About

Medpace Holdings, Inc. Common Stock, also called Medpace, is a contract research organization, which engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. Read More Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August J. Troendle in July 1992 and is headquartered in Cincinnati, OH.

Employees
2,900
Headquarters
Cincinnati, Ohio
Founded
1992
Market Cap
2.01B
Price-Earnings Ratio
29.17
Dividend Yield
0.00
Average Volume
598.63K
High Today
$58.27
Low Today
$56.15
Open Price
$56.81
Volume
350.20K
52 Week High
$71.66
52 Week Low
$33.52

Collections

Business Services
Medical
Biotechnology
Pharmaceutical
Health
2016 IPO
US
North America

News

Simply Wall StMar 17

What Investors Should Know About Medpace Holdings, Inc.’s (NASDAQ:MEDP) Financial Strength

Investors are always looking for growth in small-cap stocks like Medpace Holdings, Inc. (NASDAQ:MEDP), with a market cap of US$2.0b. However, an important fact which most ignore is: how financially healthy is the business? Assessing first and foremost the financial health is essential, since poor capital management may bring about bankruptcies, which occur at a higher rate for small-caps. Let’s work through some financial health checks you may wish to consider if you’re interested in this stock. Nevertheles...

68
Yahoo FinanceMar 14

Medpace (MEDP) Q4 Earnings and Revenues Top Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 10.14% and 4.04%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

46
Yahoo FinanceMar 12

What Are Analysts Saying About Medpace Holdings, Inc.’s (NASDAQ:MEDP) Long Term Outlook?

In December 2018, Medpace Holdings, Inc. (NASDAQ:MEDP) announced its latest earnings update, which showed that the business experienced a large tailwind, leading to a high double-digit earnings growth of 87%. Today I want to provide a brief commentary on how market analysts view Medpace Holdings’s earnings growth trajectory over the next couple of years and whether the future looks even brighter than the past. I will be using net income excluding extraordinary items in order to exclude one-off volatility wh...

44

Earnings

$0.30
$0.45
$0.61
$0.76
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 29, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.